6 Implementation

6 Implementation

6.1 NICE intends to develop tools, in association with relevant stakeholders, to help organisations put this guidance into practice.

6.2 Genomic Health, Myriad Genetics and NanoString Technologies have all offered their tumour profiling tests to the NHS under access proposals that make each test available to the NHS at a revised price. The proposal prices are commercial in confidence. It is the responsibility of the companies to communicate details of their proposal to the relevant NHS organisations.

  • National Institute for Health and Care Excellence (NICE)